Kerry Wentworth sold $904K of Nuvation Bio (NUVB)

Executed Apr 6, disclosed Apr 8, 2 days later.

Value, as filed

$904K

200,000 sh × $4.52

Executed

Apr 6

the trade date, as filed

Disclosed

Apr 8

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KW Kerry Wentworth CHIEF REGULATORY OFFICER profile →

Kerry Wentworth (CHIEF REGULATORY OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Nuvation Bio Inc. (NUVB). The largest single filing was $904K of NUVB (200,000 sh × $4.52, as filed), executed Apr 6.

The name

NUVB Nuvation Bio Inc. NUVB · Healthcare · 18 filings in 24 months ticker →

Healthcare · Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kerry Wentworth in NUVB

NUVBSALE Nuvation Bio Inc. $379K
63,000 sh × $6.02
Exec Jun 23
Filed Jun 24 · 5:30 PM ET NUVBSALE Nuvation Bio Inc. $184K
36,750 sh × $5.01
Exec Apr 17
Filed Apr 21 · 5:30 PM ET